Earnings Feed
Start Free
Home/Filings/4/0001225208-23-002810
4//SEC Filing

Denton David M 4

Accession 0001225208-23-002810

CIK 0000078003other
View on SEC.govCompany Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 8:17 PM ET

Size

8.1 KB

Accession

0001225208-23-002810

Insider Transaction Report

Form 4
Period: 2023-02-23
PFIZER INCPFE
Denton David M
Chief Financial Officer & EVP
Transactions
  • Award

    Stock Appreciation Rights

    2023-02-23+103,320→ 103,320 total
    Exercise: $42.30From: 2028-02-23Exp: 2028-02-23→ Common Stock (103,320 underlying)
  • Award

    Stock Appreciation Rights

    2023-02-23+89,920→ 89,920 total
    Exercise: $42.30From: 2030-02-23Exp: 2030-02-23→ Common Stock (89,920 underlying)
Holdings

  • Common Stock

    63,756
Footnotes (2)
  • [F1]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
  • [F2]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

→
Entity typeother

Related Parties

1
  • filerCIK 0001428718

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:17 PM ET
Size
8.1 KB
View on SEC.gov